Clinical trialNCT02556788CompletedPhase 3Interventional

Double-Blind Efficacy and Safety of CD5789 (Trifarotene) 50µg/g Cream Versus Vehicle Cream in Acne Vulgaris

SponsorGalderma R&DEnrollment1,212Acne Vulgaris

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Kevin Chan
Galderma R&D
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

81 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Czechia

Galderma Investigational Site
Chomutov, Czechia
Galderma Investigational Site
Hradec Králové, Czechia
Galderma Investigational Site
Kutná Hora, Czechia
Galderma Investigational Site
Olomouc, Czechia
Galderma Investigational Site
Pardubice, Czechia
Galderma Investigational Site
Prague, Czechia
Galderma Investigational Site
Prague, Czechia
Galderma Investigational Site
Prague, Czechia

Hungary

Galderma Investigational Site
Budapest, Hungary
Galderma Investigational Site
Budapest, Hungary
Galderma Investigational Site
Debrecen, Hungary
Galderma Investigational Site
Miskolc, Hungary
Galderma Investigational Site
Pécs, Hungary
Galderma Investigational Site
Szeged, Hungary
Galderma Investigational Site
Szolnok, Hungary

Poland

Galderma Investigational Site
Bialystok, Poland
Galderma Investigational Site
Gdansk, Poland
Galderma Investigational Site
Gdansk, Poland
Galderma Investigational Site
Gdansk, Poland
Galderma Investigational Site
Katowice, Poland
Galderma Investigational Site
Katowice, Poland
Galderma Investigational Site
Katowice, Poland
Galderma Investigational Site
Lodz, Poland
Galderma Investigational Site
Sochaczew, Poland
Galderma Investigational Site
Warsaw, Poland
Galderma Investigational Site
Warsaw, Poland
Galderma Investigational Site
Warsaw, Poland
Galderma Investigational Site
Wroclaw, Poland
Galderma Investigational Site
Wroclaw, Poland

Romania

Galderma Investigational Site
Brasov, Romania
Galderma Investigational Site
Craiova, Romania
Galderma Investigational Site
Iași, Romania
Galderma Investigational Site
Târgu Mureş, Romania

Russia

Galderma Investigational Site
Krasnodar, Russia
Galderma Investigational Site
Lipetsk, Russia
Galderma Investigational Site
Moscow, Russia
Galderma Investigational Site
Moscow, Russia
Galderma Investigational Site
Moscow, Russia
Galderma Investigational Site
Saint Petersburg, Russia
Galderma Investigational Site
Sr Petersburg, Russia

41 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Nov 2015
Primary completion: 7 Feb 2017
Completion: 12 May 2017
Last update posted: 12 Nov 2019
Registered enrollment: 1,212
Registry id: NCT02556788

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.